Use of biochemical tests of placental function for improving pregnancy outcome

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Heazell, Alexander E P ^a   Whitworth, Melissa ^b   Duley, Lelia ^c   Thornton, Jim G ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; BIOCHEMICAL ANALYSIS; CESAREAN SECTION; ECLAMPSIA; FETUS DISEASE; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HUMAN; INTERVENTION STUDY; LOW RISK PATIENT; MATERNAL DEATH; MULTIPLE ORGAN FAILURE; NEONATAL INTENSIVE CARE UNIT; NERVE CELL DIFFERENTIATION; NEWBORN DEATH; NEWBORN MORBIDITY; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PLACENTAL FUNCTION TEST; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; REVIEW; STILLBIRTH; SYSTEMATIC REVIEW; UMBILICAL ARTERY;

EID: 85041680191     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011202     Document Type: Review

References (20)

1. Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 8. [DOI: 10.1002/14651858.CD001450.pub3]
2. Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007529.pub2]
3. Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, et al.Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?. American Journal of Obstetrics and Gynecology 2012;206(2):163.e1-7. [PUBMED: 22055338]
4. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology 2011;204(3):193-201. [PUBMED: 21094932]
5. Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG: an international journal of obstetrics and gynaecology 2013;120(6):681-94. [PUBMED: 23398929]
6. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al.First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). American Journal of Obstetrics and Gynecology 2004;191(4):1446-51. [PUBMED: 15507981]
7. Dutton PJ, Warrander LK, Roberts SA, Bernatavicius G, Byrd LM, Gaze D, et al.Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study. PloS one 2012;7(7):e39784. [PUBMED: 22808059]
8. Greene JW Jr, Duhring JL, Smith K. Placental function tests. A review of methods available for assessment of the fetoplacental complex. American Journal of Obstetrics and Gynecology 1965;92:1030-58. [PUBMED: 14321104]
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Horgan RP, Broadhurst DI, Walsh SK, Dunn WB, Brown M, Roberts CT, et al.Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. Journal of Proteome Research 2011;10(8):3660-73. [PUBMED: 21671558]
11. Neilson JP. Biochemical tests of placental function for assessment in pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD000108.pub2]
12. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. American Journal of Obstetrics and Gynecology 2006;195(1):40-9. [PUBMED: 16813742]
13. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins HK, Shehata B, et al.Placental findings in singleton stillbirths. Obstetrics and Gynecology 2014;123(2 Pt 1):325-36. [PUBMED: 24402599]
14. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
15. Saffer C, Olson G, Boggess KA, Beyerlein R, Eubank C, Sibai BM. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Hypertension in Pregnancy 2013;3(2):124-32.
16. Schneuer FJ, Nassar N, Khambalia AZ, Tasevski V, Guilbert C, Ashton AW, et al.First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review. Placenta 2012;33(9):735-40. [PUBMED: 22748852]
17. Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al.Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstetrics and Gynecology 2007;109(6):1316-24. [PUBMED: 17540803]
18. Smith GC, Shah I, White IR, Pell JP, Crossley JA, Dobbie R. Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG: an international journal of obstetrics and gynaecology 2007;114(6):705-14. [PUBMED: 17516962]
19. Warrander LK, Batra G, Bernatavicius G, Greenwood SL, Dutton P, Jones RL, et al.Maternal perception of reduced fetal movements is associated with altered placental structure and function. PloS one 2012;7(4):e34851. [PUBMED: 22523561]
20. Neilson JP. Biochemical tests of placental function for assessment in pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD000108.pub2]